Results 211 to 220 of about 324,898 (311)
Potential for use of Al/machine learning for pharmacovigilance: Is there a role for regulators?
British Journal of Clinical Pharmacology, EarlyView.
Christina Gao +3 more
wiley +1 more source
Background Reporting adverse drug reactions (ADRs) is essential for drug safety. In Switzerland, healthcare professionals are legally required to report serious and unlabelled ADRs, yet under‐reporting remains widespread. We tested a novel method to increase reporting of ADR‐related hospitalizations.
Georgia Anita Weber +7 more
wiley +1 more source
Artificial Intelligence in Mental Health Services Under Illinois Public Act 104-0054: Legal Boundaries and a Framework for Establishing Safe, Effective AI Tools. [PDF]
Szoke D, Pridgen S, Held P.
europepmc +1 more source
The future in a bubble: Supporting Finnish early childhood professionals working in diverse settings
Abstract The purpose of this study was to contribute to the knowledge about early childhood education and care (ECEC) personnel's perception of the support structures that are most effective in assisting them in their work with culturally and linguistically diverse children.
Alexandra C. Anton +2 more
wiley +1 more source
The history of state preemption and medical device regulation: lessons for artificial intelligence oversight. [PDF]
Thomason C +3 more
europepmc +1 more source
openaire +1 more source
Abstract This article considers how teachers' professional development could be redeveloped to help address the current crisis in teacher recruitment and retention by offering greater intellectual rigour and more opportunities for intellectual growth. Our analysis is focused on the UK government's current policy for leadership development in schools in
Mark Innes +2 more
wiley +1 more source
The regulation of artificial intelligence in intensive care units: from narrow tools to generalist systems. [PDF]
Freyer O +9 more
europepmc +1 more source

